At their February 20 meeting, the Gainesville City Commission increased residential trash collection fees by 20%, passed a ...

Amicus Therapeutics has two products in the market that generated more than $528 million in revenue last year.

Amicus Therapeutics (NASDAQ:FOLD – Free Report) had its price objective cut by Wells Fargo & Company from $18.00 to $17.00 in ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Nagpur: With wildlife tourism picking up pace, buffer zones of Maharashtra's national parks, tiger reserves, and wildlife ...

The FDIC withdrew its amicus brief supporting Colorado's opt-out law on interest rate exportation, highlighting the agency's ...

Learn more about whether Amicus Therapeutics, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor ...

"Working families need the CFPB, especially as rising prices are making it hard to make ends meet and put food on the table." ...

The group, including mayors from San Francisco, Baltimore, St. Louis and Cleveland, says Trump's NIH cuts would "undermine ...

Wilderness Battlefield has so many lessons left to teach us. But those lessons are about war, loss, and reconciliation, not ...

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -10% and 0.13%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?